{"id":"https://openalex.org/W2010937018","doi":"https://doi.org/10.1016/s0140-6736(97)24021-3","title":"Second-generation non-nucleosidic reverse transcriptase inhibitor HBY097 and HIV-1 viral load","display_name":"Second-generation non-nucleosidic reverse transcriptase inhibitor HBY097 and HIV-1 viral load","publication_year":1997,"publication_date":"1997-05-01","ids":{"openalex":"https://openalex.org/W2010937018","doi":"https://doi.org/10.1016/s0140-6736(97)24021-3","mag":"2010937018","pmid":"https://pubmed.ncbi.nlm.nih.gov/9167463"},"language":"en","primary_location":{"id":"doi:10.1016/s0140-6736(97)24021-3","doi":"https://doi.org/10.1016/s0140-6736(97)24021-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0140-6736(97)24021-3","pdf_url":null,"source":{"id":"https://openalex.org/S49861241","display_name":"The Lancet","issn_l":"0099-5355","issn":["0099-5355","0140-6736","1474-547X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057497318","display_name":"Helga R\u00fcbsamen\u2010Waigmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["CA","DE","US"],"is_corresponding":true,"raw_author_name":"Helga R\u00fcbsamen-Waigmann","raw_affiliation_strings":["Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany; Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA; Hoechst AG, General Pharma Research, Frankfurt, Germany; and McGill University AIDS Centre, Montreal, Quebec, Canada","Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany","Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA","Hoechst AG, General Pharma Research, Frankfurt, Germany","McGill University AIDS Centre, Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany; Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA; Hoechst AG, General Pharma Research, Frankfurt, Germany; and McGill University AIDS Centre, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Hoechst AG, General Pharma Research, Frankfurt, Germany","institution_ids":[]},{"raw_affiliation_string":"McGill University AIDS Centre, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062844436","display_name":"Edward D. Huguenel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["CA","DE","US"],"is_corresponding":false,"raw_author_name":"Edward Huguenel","raw_affiliation_strings":["Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany; Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA; Hoechst AG, General Pharma Research, Frankfurt, Germany; and McGill University AIDS Centre, Montreal, Quebec, Canada","Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany","Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA","Hoechst AG, General Pharma Research, Frankfurt, Germany","McGill University AIDS Centre, Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany; Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA; Hoechst AG, General Pharma Research, Frankfurt, Germany; and McGill University AIDS Centre, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Hoechst AG, General Pharma Research, Frankfurt, Germany","institution_ids":[]},{"raw_affiliation_string":"McGill University AIDS Centre, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023407749","display_name":"Arno Paessens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["CA","DE","US"],"is_corresponding":false,"raw_author_name":"Arno Paessens","raw_affiliation_strings":["Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany; Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA; Hoechst AG, General Pharma Research, Frankfurt, Germany; and McGill University AIDS Centre, Montreal, Quebec, Canada","Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany","Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA","Hoechst AG, General Pharma Research, Frankfurt, Germany","McGill University AIDS Centre, Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany; Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA; Hoechst AG, General Pharma Research, Frankfurt, Germany; and McGill University AIDS Centre, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Hoechst AG, General Pharma Research, Frankfurt, Germany","institution_ids":[]},{"raw_affiliation_string":"McGill University AIDS Centre, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111951927","display_name":"J\u0151rg\u2010Peter Kleim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["CA","DE","US"],"is_corresponding":false,"raw_author_name":"J\u00f6rg-Peter Kleim","raw_affiliation_strings":["Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany; Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA; Hoechst AG, General Pharma Research, Frankfurt, Germany; and McGill University AIDS Centre, Montreal, Quebec, Canada","Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany","Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA","Hoechst AG, General Pharma Research, Frankfurt, Germany","McGill University AIDS Centre, Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany; Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA; Hoechst AG, General Pharma Research, Frankfurt, Germany; and McGill University AIDS Centre, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Hoechst AG, General Pharma Research, Frankfurt, Germany","institution_ids":[]},{"raw_affiliation_string":"McGill University AIDS Centre, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029881635","display_name":"Mark A. Wainberg","orcid":"https://orcid.org/0000-0002-0272-1317","observed_orcids":["https://orcid.org/0000-0002-0272-1317"]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["CA","DE","US"],"is_corresponding":false,"raw_author_name":"Mark A Wainberg","raw_affiliation_strings":["Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany; Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA; Hoechst AG, General Pharma Research, Frankfurt, Germany; and McGill University AIDS Centre, Montreal, Quebec, Canada","Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany","Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA","Hoechst AG, General Pharma Research, Frankfurt, Germany","McGill University AIDS Centre, Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany; Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA; Hoechst AG, General Pharma Research, Frankfurt, Germany; and McGill University AIDS Centre, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Hoechst AG, General Pharma Research, Frankfurt, Germany","institution_ids":[]},{"raw_affiliation_string":"McGill University AIDS Centre, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061647772","display_name":"Anita Shah","orcid":"https://orcid.org/0000-0002-7846-3115","observed_orcids":["https://orcid.org/0000-0002-7846-3115"]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["CA","DE","US"],"is_corresponding":false,"raw_author_name":"Anita Shah","raw_affiliation_strings":["Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany; Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA; Hoechst AG, General Pharma Research, Frankfurt, Germany; and McGill University AIDS Centre, Montreal, Quebec, Canada","Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany","Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA","Hoechst AG, General Pharma Research, Frankfurt, Germany","McGill University AIDS Centre, Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany; Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA; Hoechst AG, General Pharma Research, Frankfurt, Germany; and McGill University AIDS Centre, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Bayer Pharma Research Centre, Anti-infectives Research, Aprather Weg, 42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Research Centre, Pharmaceutical Division, West Haven, CT, USA","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Hoechst AG, General Pharma Research, Frankfurt, Germany","institution_ids":[]},{"raw_affiliation_string":"McGill University AIDS Centre, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5057497318"],"corresponding_institution_ids":["https://openalex.org/I150569930","https://openalex.org/I4405287669","https://openalex.org/I5023651","https://openalex.org/I67348948"],"apc_list":{"value":7890,"currency":"USD","value_usd":7890},"apc_paid":null,"fwci":1.983,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.86125146,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"349","issue":"9064","first_page":"1517","last_page":"1517"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.953000009059906},{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.8339999914169312},{"id":"https://openalex.org/keywords/viral-load","display_name":"viral load","score":0.8650000095367432},{"id":"https://openalex.org/keywords/nevirapine","display_name":"nevirapine","score":0.7440000176429749},{"id":"https://openalex.org/keywords/zidovudine","display_name":"zidovudine","score":0.9089999794960022},{"id":"https://openalex.org/keywords/didanosine","display_name":"didanosine","score":0.996999979019165},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.9419999718666077},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8199999928474426},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.5460000038146973}],"concepts":[{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.8516889214515686},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6810398101806641},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.6492316722869873},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.6392837762832642},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5803775787353516},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46101394295692444},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.30378931760787964},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23765715956687927},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.12259671092033386},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07638344168663025},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004352","descriptor_name":"Drug Resistance, Microbial","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014766","descriptor_name":"Viremia","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0140-6736(97)24021-3","doi":"https://doi.org/10.1016/s0140-6736(97)24021-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0140-6736(97)24021-3","pdf_url":null,"source":{"id":"https://openalex.org/S49861241","display_name":"The Lancet","issn_l":"0099-5355","issn":["0099-5355","0140-6736","1474-547X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet","raw_type":"journal-article"},{"id":"pmid:9167463","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9167463","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lancet (London, England)","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W1973398091","https://openalex.org/W1997330869","https://openalex.org/W2090137444"],"related_works":["https://openalex.org/W2072320892","https://openalex.org/W2143910776","https://openalex.org/W2076284523","https://openalex.org/W4243960249","https://openalex.org/W2146795191","https://openalex.org/W1997330869","https://openalex.org/W7098543987","https://openalex.org/W2117784959","https://openalex.org/W61169677","https://openalex.org/W2342950203"],"abstract_inverted_index":null,"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}